BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Satış H, Oruç A, Avcu A, Karadeniz H, Güler AA, Kayahan N. Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry. Rheumatology (Oxford) 2020;59:2180. [PMID: 32442283 DOI: 10.1093/rheumatology/keaa171] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Vadillo C, Nieto MA, Romero-bueno F, Leon L, Sanchez-pernaute O, Rodriguez-nieto MJ, Freites D, Jover LJA, Álvarez-sala JL, Abasolo L. Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry: reply. Rheumatology 2020;59:2181-2182. [DOI: 10.1093/rheumatology/keaa160] [Reference Citation Analysis]
2 Ahmad Al Nokhatha S, Harrington R, Conway R. Methotrexate and The Lung in Rheumatoid Arthritis. EMJ Rheumatol. [DOI: 10.33590/emjrheumatol/20-00074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]